Laboratory News and Research

RSS

Interdisciplinary team wins NIH grant to develop a device for early oral cancer detection

Mouth lesions are among the main early indicators of oral cancer, but determining whether a sore is actually malignant typically involves painful, costly biopsies.

28 Sep 2020

New framework allows researchers to probe the metabolic processes inside cancer cells

One of the biggest challenges to the development of medical treatments for cancer is the fact that there is no single kind of cancer.

28 Sep 2020

BAT study analyzes the toxicological impact of nicotine pouch products

New research by BAT indicates that modern oral products (MOPs) showed lower toxicity responses in certain assays than traditional cigarettes.

28 Sep 2020

Anti-N-protein IgG may predict severity of COVID-19

A recent study by researchers at the University of Miami, Miami VA Healthcare System and Express Gene and published on the preprint server medRxiv in September 2020 reports on the prognostic significance of the anti-N Immunoglobulin G (IgG) antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

28 Sep 2020

Risk factors for mortality among hospitalized patients with COVID-19

A new study by scientists at biotechnology company Genentech, Inc., and published on the preprint server medRxiv in September 2020 attempts to identify the factors which may shape the risk for death in COVID-19 disease.

27 Sep 2020

Complex SARS-CoV-2 serology means universal immunological assay is not feasible

As we improve our understanding of immune responses and correlates of protection against the severe acute respiratory syndrome coronavirus (SARS-CoV-2), two UK researchers emphasize that we will probably utilize different assays to tackle specific questions. Their commentary is published in the prestigious journal Lancet Infectious Diseases.

27 Sep 2020

Masks and face coverings are effective in reducing the spread of airborne particles

Laboratory tests of surgical and N95 masks by researchers at the University of California, Davis, show that they do cut down the amount of aerosolized particles emitted during breathing, talking and coughing.

26 Sep 2020

Yale designates three independent laboratories to perform SalivaDirect COVID-19 test

Yale has designated three independent laboratories to perform the university-developed SalivaDirectTM COVID-19 test.

26 Sep 2020

Translational research training program helps students to better understand patients' problems

Translational research aims to speed research breakthroughs into the clinic. And yet, training for basic scientists and clinicians too often remains siloed, leading to divergent cultures and a loss of opportunity for cross-disciplinary collaboration.

26 Sep 2020

AXT add Vieworks bio-imaging solutions to their preclinical imaging portfolio

AXT is excited to add the Vieworks range of bio-imaging systems to their preclinical imaging product portfolio. Their in-vivo imaging systems provide outstanding performance in bioluminescent and fluorescent imaging and represents excellent value.

From AXT Pty Ltd 26 Sep 2020

Combination of heat and high relative humidity can disinfect N95 mask materials

As the COVID-19 pandemic swept around the world early this year, shortages of protective equipment such as N95 masks left healthcare workers little choice but to reuse the masks they had - increasing the risk of infection for both them and their patients.

26 Sep 2020

Shorter time from COVID-19 symptom onset to hospitalization linked to disease severity, death

New research presented at this week's ESCMID Conference on Coronavirus Disease (ECCVID, held online) shows that a shorter time from symptom onset to hospitalization is associated with more serious disease and death in patients with COVID-19.

26 Sep 2020

Researchers develop a stable nano-carrier for medications

Medications often have unwanted side-effects. One reason is that they reach not only the unhealthy cells for which they are intended, but also reach and have an impact on healthy cells.

25 Sep 2020

New trial tests combination antibody treatment for preventing COVID-19 illness

A combination antibody treatment for preventing COVID-19 illness in individuals who have had sustained exposure to someone with the virus is being studied by researchers at The University of Texas Health Science Center at Houston.

25 Sep 2020

Study demonstrates a proof-of-concept stem cell treatment in Parkinson's disease mouse model

The mature brain is infamously bad at repairing itself following damage like that caused by trauma or strokes, or from degenerative diseases like Parkinson's. Stem cells, which are endlessly adaptable, have offered the promise of better neural repair.

25 Sep 2020

3D-printed alternative performs as well as the standard nasal swabs for COVID-19 testing

As COVID-19 quickly spread worldwide this spring, shortages of supplies, including the nasopharyngeal (nasal) swabs used to collect viral samples, limited diagnostic testing.

25 Sep 2020

UMass Amherst epidemiologist receives NIH grant to develop new tick surveillance method

A University of Massachusetts Amherst infectious disease epidemiologist has received a grant from the National Institutes of Health to develop a new surveillance method to better identify specific locations with the highest risk for tick-borne disease transmission.

25 Sep 2020

New suite of human blood biomarkers can improve stroke diagnosis

An interdisciplinary group of researchers at the Frances Payne Bolton School of Nursing at Case Western Reserve University have uncovered a new suite of human blood biomarkers which could someday help emergency clinicians quickly recognize whether someone is experiencing a stroke with a simple blood test.

25 Sep 2020

TL1A and its receptor could reduce fibrosis and tissue remodeling in patients with severe lung disease

Your lungs and airways need to be stretchy, sort of like balloons. Take a big breath, and they'll open right up.

25 Sep 2020

Faulty genes and an autoimmune condition linked to severe COVID-19 in young, healthy people

More than 10 percent of young and healthy people who develop severe COVID-19 have misguided antibodies that attack not the virus, but the immune system itself, new research shows. Another 3.5 percent, at least, carry a specific kind of genetic mutation.

25 Sep 2020

Laboratory News and Research

Interdisciplinary team wins NIH grant to develop a device for early oral cancer detection

New framework allows researchers to probe the metabolic processes inside cancer cells

BAT study analyzes the toxicological impact of nicotine pouch products

Anti-N-protein IgG may predict severity of COVID-19

Risk factors for mortality among hospitalized patients with COVID-19

Complex SARS-CoV-2 serology means universal immunological assay is not feasible

Masks and face coverings are effective in reducing the spread of airborne particles

Yale designates three independent laboratories to perform SalivaDirect COVID-19 test

Translational research training program helps students to better understand patients' problems

AXT add Vieworks bio-imaging solutions to their preclinical imaging portfolio

Combination of heat and high relative humidity can disinfect N95 mask materials

Shorter time from COVID-19 symptom onset to hospitalization linked to disease severity, death

Researchers develop a stable nano-carrier for medications

New trial tests combination antibody treatment for preventing COVID-19 illness

Study demonstrates a proof-of-concept stem cell treatment in Parkinson's disease mouse model

3D-printed alternative performs as well as the standard nasal swabs for COVID-19 testing

UMass Amherst epidemiologist receives NIH grant to develop new tick surveillance method

New suite of human blood biomarkers can improve stroke diagnosis

TL1A and its receptor could reduce fibrosis and tissue remodeling in patients with severe lung disease

Faulty genes and an autoimmune condition linked to severe COVID-19 in young, healthy people

Pittcon 2024 - Advancing Science on the West Coast eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo